Table 1.

Patient characteristics

	Cohort 1	Cohort 2
	n=63	n=39
Baseline Characteristics
Mean Age (range)	62 (48–82)	61 (40–77)
Median Gleason Score (range)	7 (6–10)	7 (6–9)
Median Baseline PSA Level, ng/ml (range)	18 (0.67–122)	13 (2–3692)
Median Baseline Testosterone, ng/dL (range)	298 (169–579)	306 (148–475)
Disease State
Rising PSA	25 (40%)	18 (46%)
Non-castrate Metastatic	38 (60%)	21 (54%)
Primary Therapy
Radical Prostatectomy Alone	37 (59%)	22 (56%)
Radiation Therapy Alone	6 (10%)	6 (15%)
Salvage Radiation Therapy	16 (25%)	9 (23%)
No Prior Treatment	3 (5%)	2 (5%)